Clarity Pharmaceuticals Ltd (ASX: CU6)
Australia
· Delayed Price · Currency is AUD
5.97
-0.09 (-1.49%)
Nov 21, 2024, 4:10 PM AEST
Clarity Pharmaceuticals Cash Flow Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
Jun '24 Jun 30, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 |
Net Income | -42.32 | -42.32 | -24.6 | -23.75 | -10.22 | -6.95 | |
Depreciation & Amortization | 0.15 | 0.15 | 0.1 | 0.05 | 0.02 | 0.02 | |
Loss (Gain) From Sale of Assets | 0 | 0 | - | - | 0 | 0 | |
Stock-Based Compensation | 4.17 | 4.17 | 1.25 | 8.77 | 2.07 | 1.19 | |
Other Operating Activities | - | - | - | 0 | - | - | |
Change in Accounts Receivable | -2.63 | -2.63 | -3.34 | -3.29 | -0.71 | -0.92 | |
Change in Accounts Payable | 0.26 | 0.26 | 0.02 | 5.01 | 1.07 | -0.25 | |
Change in Unearned Revenue | - | - | - | -0.08 | -0.03 | -0.04 | |
Change in Other Net Operating Assets | -2.87 | -2.87 | -0.92 | -0.01 | 0.13 | 0.12 | |
Operating Cash Flow | -43.24 | -43.24 | -27.5 | -13.31 | -7.68 | -6.83 | |
Capital Expenditures | -0.5 | -0.5 | -0.05 | -0.21 | -0.06 | -0.01 | |
Investment in Securities | -54.8 | -54.8 | 3.2 | -26.5 | -9.5 | - | |
Investing Cash Flow | -55.31 | -55.31 | 3.15 | -26.71 | -9.56 | -0.01 | |
Issuance of Common Stock | 121.86 | 121.86 | 0.24 | 92.53 | 21.1 | 4.7 | |
Other Financing Activities | -6.65 | -6.65 | -0.01 | -5.6 | -0.68 | 3.51 | |
Financing Cash Flow | 115.21 | 115.21 | 0.23 | 86.93 | 20.41 | 8.22 | |
Foreign Exchange Rate Adjustments | 0.02 | 0.02 | -0.01 | -0 | -0 | 0 | |
Net Cash Flow | 16.69 | 16.69 | -24.12 | 46.9 | 3.17 | 1.37 | |
Free Cash Flow | -43.74 | -43.74 | -27.55 | -13.53 | -7.74 | -6.84 | |
Free Cash Flow Margin | -380.14% | -380.14% | -281.07% | -209.43% | -242.06% | -245.44% | |
Free Cash Flow Per Share | -0.16 | -0.16 | -0.11 | -0.05 | -0.04 | -0.05 | |
Cash Interest Paid | - | - | - | - | 0 | 0.01 | |
Cash Income Tax Paid | 0.08 | 0.08 | 0.1 | 0.02 | - | - | |
Levered Free Cash Flow | -29.52 | -29.52 | -19.59 | -7.23 | -3.9 | -4.3 | |
Unlevered Free Cash Flow | -29.52 | -29.52 | -19.59 | -7.23 | -3.9 | -4.3 | |
Change in Net Working Capital | 5.35 | 5.35 | 4.41 | -1.61 | -0.52 | 1.08 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.